These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 7909419

  • 1. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P.
    Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P, Rantanen V, Kulmala J, Heiskanen J, Grenman S.
    Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
    [Abstract] [Full Text] [Related]

  • 5. The scientific rationale for developing taxoids.
    Aapro M.
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD.
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [Abstract] [Full Text] [Related]

  • 9. Docetaxel and paclitaxel inhibit DNA-adduct formation and intracellular accumulation of cisplatin in human leukocytes.
    Ma J, Verweij J, Planting AS, Kolker HJ, Loos WJ, de Boer-Dennert M, van der Burg ME, Stoter G, Schellens JH.
    Cancer Chemother Pharmacol; 1996 Apr; 37(4):382-4. PubMed ID: 8548886
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
    Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D.
    J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
    [Abstract] [Full Text] [Related]

  • 14. [Taxotere: from yew's needles to clinical practice].
    Lavelle F, Gueritte-Voegelein F, Guenard D.
    Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
    Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G.
    Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of docetaxel (Taxotere).
    Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S.
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J, Clavel M, Chevalier B.
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [Abstract] [Full Text] [Related]

  • 19. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C, Niell H, Miller A, Cox C.
    Cancer Chemother Pharmacol; 1994 Jul; 33(6):460-4. PubMed ID: 7907952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.